Pubblicazioni

Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?

2019 - ANNALS OF NUCLEAR MEDICINE

Chiaravalloti, A.; Esposito, V.; Ursini, F.; Di Giorgio, E.; Zinzi, M.; Calabria, F.; Cimini, A.; Schillaci, O.

68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung Carcinoid

2018 - CLINICAL NUCLEAR MEDICINE

Leccisotti, L.; Lorusso, M.; Giannetta, E.; Isidori, A. M.; Rufini, V.

Imaging biomarkers in prostate cancer: role of PET/CT and MRI

2015 - EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Picchio, M.; Mapelli, P.; Panebianco, V.; Castellucci, P.; Incerti, E.; Briganti, A.; Gandaglia, G.; Kirienko, M.; Barchetti, F.; Nanni, C.; Montorsi, F.; Gianolli, L.; Fanti, S.